The weekly litigation news digest is live. Subscribe now

IP Verse

Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof - EP2838548

The patent EP2838548 was granted to University OF Washington Through ITS Center FOR Commercialization on Jul 19, 2023. The application was originally filed on Mar 15, 2013 under application number EP13714128A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2838548

UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Application Number
EP13714128A
Filing Date
Mar 15, 2013
Status
Granted And Under Opposition
Jun 16, 2023
Publication Date
Jul 19, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PAGEApr 16, 2024PAGEADMISSIBLE
JAMES POOLEAug 3, 2023CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2008219956
DESCRIPTIONUS4892538
DESCRIPTIONUS5011472
DESCRIPTIONUS5837234
DESCRIPTIONWO9110425
DESCRIPTIONWO9110470
EXAMINATIONWO2012145384
EXAMINATIONWO9209688
EXAMINATIONWO9517911
OPPOSITIONUS2005196404
OPPOSITIONUS6514752
OPPOSITIONWO2007091078
OPPOSITIONWO2012145384
OPPOSITIONWO9209688
OPPOSITIONWO9517911

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents